Stock Events

Stock Events

Visioneering Technologies 

A$0.07
3
-A$0-1.49% Wednesday 00:27

Statistics

Day High
0.07
Day Low
0.07
52W High
0.23
52W Low
0.04
Volume
12,658
Avg. Volume
151,502
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

24MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-39.79%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
12.87MRevenue
-5.12MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VTI.AU. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cooper Companies
COO
Mkt Cap12.17B
Cooper Companies operates through CooperVision, which manufactures and markets contact lenses, directly competing in the vision correction sector.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson provides a range of healthcare products including contact lenses through its Vision Care, Inc. subsidiary, competing in similar markets as Visioneering Technologies.
Bausch Health Companies
BHC
Mkt Cap2.11B
Bausch Health Companies, through its division Bausch + Lomb, offers contact lenses and eye health products, serving the same customer base as Visioneering Technologies.
Alcon
ALC
Mkt Cap37.03B
Alcon focuses on eye care products including contact lenses, directly competing with Visioneering Technologies in the vision care market.
National Vision
EYE
Mkt Cap1.89B
National Vision Holdings, Inc. operates a network of optometry and vision retail services, offering products that compete with those of Visioneering Technologies.
Straumann
STMN.SW
Mkt Cap13.47B
The Straumann Group provides various healthcare products and services, including those for vision care, competing in the same market as Visioneering Technologies.
3M
MMM
Mkt Cap74.32B
3M Company, through its health care segment, offers products that include eye health solutions, indirectly competing with Visioneering Technologies in the healthcare market.

About

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.
Show more...
CEO
Dr. Juan Carlos Aragon
Country
United States
ISIN
AU000000VTI2

Listings

0 Comments

Share your thoughts

FAQ

What is Visioneering Technologies stock price today?▼
The current price of VTI.AU is A$0.07 AUD — it has decreased by -1.49% in the past 24 hours. Watch Visioneering Technologies stock price performance more closely on the chart.
What is Visioneering Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Visioneering Technologies stocks are traded under the ticker VTI.AU.
What is Visioneering Technologies revenue for the last year?▼
Visioneering Technologies revenue for the last year amounts to 12.87M AUD.
What is Visioneering Technologies net income for the last year?▼
VTI.AU net income for the last year is -5.12M AUD.
In which sector is Visioneering Technologies located?▼
Visioneering Technologies operates in the Health & Wellness sector.
When did Visioneering Technologies complete a stock split?▼
The last stock split for Visioneering Technologies was on June 18, 2021 with a ratio of 1:100.
Where is Visioneering Technologies headquartered?▼
Visioneering Technologies is headquartered in Alpharetta, United States.